In an attempt to shore up both the reputation and functionality of the nations's largest state-funded cancer agency, officials at the Cancer Prevention and Research Institute of Texas (CPRIT) just announced the appointment of Dr. Margaret Kripke as the agency's new chief scientific officer. The embattled agency has faced accusations from many of its key scientists that irregularities and favoritism in the funding process have undermined their scientific credibility and put commercialization above research.
0 Comments Click here to read/write comments
Tags: cancer research, women in science, Texas A&M University, Texas Medical Center, Texas, Southwest, 2012, College Station, BioResearch Product Faire Event, Funding, Houston
Storms both meteorological and political have dominated the front page news in the past month, but the upset that has rocked Texas' Cancer Prevention & Research Institute (CPRIT) since the spring continues to make headlines in the science press. The journal Nature has published regular editorials since the flap began, intensifying in late October with the exodus of chief scientific officer and Nobel winner Alfred Gilman (right) and nearly 30 other scientists from the state cancer funding agency's review board. Here is our recap of the story, the issues at stake, and a look at where CPRIT is positioned to go from here.
0 Comments Click here to read/write comments
Tags: cancer research, Texas A&M University, Texas Medical Center, Texas, 2012, College Station, TAMU, tmc, BioResearch Product Faire Event, Houston
No one escapes being affected by cancer. We all know someone, perhaps even a family member who has been diagnosed with cancer. According to the National Cancer Institute, more than 1.6 million people will be diagnosed with cancer in 2012. In fact, it is estimated that each person has a 41% chance of developing cancer during his or her lifetime. But new discoveries by researchers have started to change the outcome of a cancer diagnosis. In a recently published article in Nature, two researchers at CU boulder have found a possible solution hiding at the ends of our DNA. According to Professor Cech, "This is an exciting scientific discovery that gives us a new way of looking at the problem of cancer.” The researchers, Tom Cech and Leslie Leinwand, found the solution by studying how telomerase functions in our cells. In normal people, telomerase helps us keep our cells healthy and young.
0 Comments Click here to read/write comments
Tags: Bioresearch, University of Colorado, Northwest, cancer research, Biofrontiers Institute, Cancer, BioResearch Product Faire Event, CO, Boulder, UCO
Often growing up as a child you hear, “eat your veggies if you want to grow up to be big and strong.” With new research on triple negative breast cancer, that old saying might have to change to "eat your veggies if you want to keep cancer away". Recently, at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Mandip Sachdeva announced: "We are confident that the compounds we are currently working with are an effective treatment for triple-negative breast cancer. These compounds are safer for the patient than current treatments available".
9 Comments Click here to read/write comments
Tags: Bioscience research, cancer research, Texas A&M University, Texas, 2012, Cancer Treatment, Cancer, College Station, BioResearch Product Faire Event, Texas A&M Research, Texas A&M Life Science Funding, TX, Texas A&M
Cancer research is hot, and the best in the field are hotly-courted by top cancer research centers, often with very attractive compensation packages in addition to state-of-the-art labs and equipment. As if fighting cancer weren't challenging enough, even renowned universities with world-class biomedical programs like the University of California San Diego have had some of their shining stars in the laboratory snatched away by big-money states like Texas in recent years. Not to be outdone or undermined, UCSD has recently engaged in some aggressive recruiting of its own and is proud to announce that two very important players in the cancer research field have joined the Moores Cancer Center faculty: Dr. Napoleone Ferrara (formerly of Genentech) and Dr. Razelle Kurzrock (formerly of MD Anderson at the University of Texas).
0 Comments Click here to read/write comments
Tags: CA, University of California San Diego, cancer research, California, 2012, Cancer Treatment, Cancer, San Diego, UCSD, Biotechnology Vendor Showcase, Cancer Center, BVS
 |
| (Courtesy of http://www.abc.net.au/) |
Every week we see commericals on television asking if we have Mesothelioma. By the number of commercials alone you would be right in thinking Mesothelioma is a serious problem. That's why it's particularly important that a major cancer research institution, the University of Hawaii Cancer Center, recently received a $600,000 grant from the Jimmy Valvano Foundation for Cancer Research. The grant was awarded to the research lab of pathologist Michele Carbone to study HGMB1: A Biomarker for Mineral Exposure and Detection of Malignant Mesothelioma. According to Dr. Carbone:
0 Comments Click here to read/write comments
Tags: biomedical research, University of Hawaii, cancer research, 2012, Hawaii, Front Line event, Honolulu, HI, Biomedical Research Funding
The University of Hawaii Cancer Center has successfully renewed its National Cancer Institute (NCI) designation and is on schedule to open its new world-class cancer research and treatment facility near the John A. Burns School of Medicine (JABSOM) in the Kaka’ako district of Honolulu early next year. The Hawaiian biomedical research center is the only NCI-level facility in the Pacific Islands and one of only 66 NCI research organizations in the U.S. The island state may be a tropical paradise and vacation destination in the popular imagination, but there's no doubt that its capital city is also becoming a serious biomedical research magnet as well.
0 Comments Click here to read/write comments
Tags: biomedical research, Bioresearch, Biomedical expansion, University of Hawaii, cancer research, New research facilities, new science wet labs, Southwest, 2012, Hawaii, Cancer, Front Line event, Honolulu, HI, new construction, Cancer Center
Medical research building construction is underway at the University of Wisconsin-Madison with high hopes for top level research once the three stages of this project have all been completed. The goal for this project, which together will be called the Wisconsin Institutes for Medical Research (WIMR), "is to create a new kind of, almost revolutionary, model for how we do medical research," said Dr. Robert Golden, dean of the UW School of Medicine and Public Health.
0 Comments Click here to read/write comments
Tags: Medical Research, cancer research, 2012, WI, Wisconsin, University of Wisconsin Madison, UW Madison, BioResearch Product Faire Event, Madison, construction
Bone marrow was the first stem cell source to be widely used in clinical transplant surgery to replace damaged bone as a result of injury or chemotherapy. Unfortunately, bone marrow grafts are painful, and the appropriate donor is not always available when the need is there. Now research at the University of California Los Angeles' Broad Center of Regenerative Medicine has demonstrated successfully that stem cells from the patient's own fat (i.e. adipose tissue) can be made usable for bone damage treatment. Bone marrow is, after all, the soft, fatty tissue inside your bones that contains immature cells (aka stem cells) that give rise to all of your blood cells. So looking to fatty tissue from another part of the body to produce mesenchymal cells has made sense all along, though it has taken the efforts of several UCLA teams to show how it can be done in an animal model.
2 Comments Click here to read/write comments
Tags: University of California Los Angeles, Stem cell research, cancer research, Southwest, California, Los Angeles, UCLA, Research, Stem Cell, Biotechnology Vendor Showcase, BVS, science solution
There's a reason why top university medical centers garner the prestige (and the funding) that they do: research labs + medical school + hospital = optimization of all three units, with ripe opportunities for collaboration, sharing of resources, and recruiting the best medical scientists. So there's always reason to cheer when a major university med center like Ohio State builds new facilities, whether they're clinical or research, because both will support the institution's overall mission and budget. In the case of Ohio State's new James Cancer Center and Solove Research Institute, both patients seeking treatment and scientists doing basic and applied cancer research will benefit from the state-of-the-art building that is rising on the Columbus medical campus right now, with its opening due in 2014. The complex will house the cancer center on 12 stories; the other 8 will comprise the critical care hospital, mechanical equipment and an as yet undetermined floor.
0 Comments Click here to read/write comments
Tags: Midwest, Ohio State University, Ohio, biomedical research, Biomedical expansion, Medical Device Technology, Biomedical Equipment, cancer research, New research facilities, new construction, Cancer Center, scientific instruments